Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kang S et al. | Altered levels of α-synuclein and sphingolipids in Batten disease lymphoblast cells. | 2014 | Gene | pmid:24534465 |
Tarhini AA et al. | Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfa. | 2014 | Melanoma Res. | pmid:24509407 |
Cachón-González MB et al. | Reversibility of neuropathology in Tay-Sachs-related diseases. | 2014 | Hum. Mol. Genet. | pmid:24057669 |
Okawa S et al. | Tolosa-hunt syndrome associated with cytomegalovirus infection. | 2013 | Intern. Med. | pmid:23676602 |
Eggermont AM et al. | Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial. | 2013 | J. Clin. Oncol. | pmid:24019551 |
Li Y et al. | Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway. | 2013 | Int. J. Biochem. Cell Biol. | pmid:23968914 |
Sato K et al. | Chemical synthesis of biologically active monoglycosylated GM2-activator protein analogue using N-sulfanylethylanilide peptide. | 2013 | Angew. Chem. Int. Ed. Engl. | pmid:23765733 |
Li Y et al. | Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma cell through enhanced phosphorylation of cMet at specific tyrosine sites and PI3K/Akt-mediated migration signaling. | 2013 | Mol. Cell. Biochem. | pmid:23749170 |
Woods AS et al. | Gangliosides and ceramides change in a mouse model of blast induced traumatic brain injury. | 2013 | ACS Chem Neurosci | pmid:23590251 |
Rupp A et al. | Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis. | 2013 | J. Peripher. Nerv. Syst. | pmid:23521648 |